Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?
作者信息
Farkas Laszlo, Goncharova Elena A
机构信息
Division of Pulmonary, Critical Care and Sleep Medicine, Department of Internal Medicine, Davis Heart and Lung Research Institute The Ohio State University Columbus OH.
Division of Pulmonary, Critical Care and Sleep Medicine, Lung Center University of California, Davis School of Medicine Davis CA.
出版信息
J Am Heart Assoc. 2022 Jul 19;11(14):e026798. doi: 10.1161/JAHA.122.026798. Epub 2022 Jul 8.
Abstract
摘要
相似文献
1
Circling In on Pulmonary Arterial Hypertension: Is It Time to Consider Circular RNA circ_0016070 as a Biomarker and Target for Therapy?
J Am Heart Assoc. 2022 Jul 19;11(14):e026798. doi: 10.1161/JAHA.122.026798. Epub 2022 Jul 8.
2
Circ-myh8/KAT7 Affects PANoptosis in Pulmonary Arterial Smooth Muscle Cells: Involvement of Super-Enhancers in FOSL2 Expression.
J Am Heart Assoc. 2025 Jul;14(13):e040334. doi: 10.1161/JAHA.124.040334. Epub 2025 Jun 18.
3
Circulating circular RNA hsa_circ_0023179 acts as a diagnostic biomarker for non-small-cell lung cancer detection.
J Cancer Res Clin Oncol. 2023 Jul;149(7):3649-3660. doi: 10.1007/s00432-022-04254-0. Epub 2022 Aug 16.
4
Hsa_circ_0088036 promotes tumorigenesis and chemotherapy resistance in hepatocellular carcinoma via the miR-140-3p/KIF2A axis.
Histol Histopathol. 2024 Nov 19:18849. doi: 10.14670/HH-18-849.
5
Circular RNA Expression of Peripheral Blood Mononuclear Cells Associated with Risk of Acute Exacerbation in Smoking Chronic Obstructive Pulmonary Disease.
Int J Chron Obstruct Pulmon Dis. 2024 Mar 20;19:789-797. doi: 10.2147/COPD.S448759. eCollection 2024.
6
StratosPHere 2: study protocol for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2.
Trials. 2024 Oct 15;25(1):680. doi: 10.1186/s13063-024-08485-z.
7
Hsa_circ_0011946 promotes the migration and invasion of hepatocellular carcinoma by inducing EMT process.
Eur Rev Med Pharmacol Sci. 2020 Feb;24(3):1108-1115. doi: 10.26355/eurrev_202002_20161.
8
Macitentan and Tadalafil Combination Therapy in Patients with Pulmonary Arterial Hypertension and Cardiovascular Comorbidities: Real-World Evidence from OPUS and OrPHeUS.
Adv Ther. 2025 May 19. doi: 10.1007/s12325-025-03180-0.
9
StratosPHere 2: statistical analysis plan for a response-adaptive randomised placebo-controlled phase II trial to evaluate hydroxychloroquine and phenylbutyrate in pulmonary arterial hypertension caused by mutations in BMPR2.
Trials. 2025 Jul 11;26(1):243. doi: 10.1186/s13063-025-08947-y.
10
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
引用本文的文献
1
Intranasal delivery of R8-modified circNFXL1 liposomes ameliorates Su5416-induced pulmonary arterial hypertension in C57BL/6 mice.
Respir Res. 2025 Apr 6;26(1):127. doi: 10.1186/s12931-025-03203-y.
2
CircRNA Galntl6 sponges miR-335 to ameliorate stress-induced hypertension through upregulating Lig3 in rostral ventrolateral medulla.
Redox Biol. 2023 Aug;64:102782. doi: 10.1016/j.redox.2023.102782. Epub 2023 Jun 9.
本文引用的文献
1
Hsa_circ_0016070/micro-340-5p Axis Accelerates Pulmonary Arterial Hypertension Progression by Upregulating TWIST1 Transcription Via TCF4/β-Catenin Complex.
J Am Heart Assoc. 2022 Jul 19;11(14):e024147. doi: 10.1161/JAHA.121.024147. Epub 2022 Jul 8.
2
Circular RNAs in pulmonary hypertension: Emerging biological concepts and potential mechanism.
Animal Model Exp Med. 2022 Feb;5(1):38-47. doi: 10.1002/ame2.12208. Epub 2022 Jan 27.
3
miR-340-5p Mediates Cardiomyocyte Oxidative Stress in Diabetes-Induced Cardiac Dysfunction by Targeting Mcl-1.
Oxid Med Cell Longev. 2022 Jan 27;2022:3182931. doi: 10.1155/2022/3182931. eCollection 2022.
4
The MFF-SIRT1/3 axis, regulated by miR-340-5p, restores mitochondrial homeostasis of hypoxia-induced pulmonary artery smooth muscle cells.
Lab Invest. 2022 May;102(5):515-523. doi: 10.1038/s41374-022-00730-w. Epub 2022 Jan 18.
5
Pulmonary Arterial Hypertension.
N Engl J Med. 2021 Dec 16;385(25):2361-2376. doi: 10.1056/NEJMra2000348.
6
CircRNAs open a new era in the study of cardiovascular disease (Review).
Int J Mol Med. 2021 Jan;47(1):49-64. doi: 10.3892/ijmm.2020.4792. Epub 2020 Nov 18.
7
Hypoxia-inducible factor signaling in pulmonary hypertension.
J Clin Invest. 2020 Nov 2;130(11):5638-5651. doi: 10.1172/JCI137558.
8
Overexpression of MicroRNA-340-5p Inhibits Pulmonary Arterial Hypertension Induced by APE by Downregulating IL-1β and IL-6.
Mol Ther Nucleic Acids. 2020 Sep 4;21:542-554. doi: 10.1016/j.omtn.2020.05.022. Epub 2020 May 22.
9
Circular RNA hsa_circ_0016070 Is Associated with Pulmonary Arterial Hypertension by Promoting PASMC Proliferation.
Mol Ther Nucleic Acids. 2019 Dec 6;18:275-284. doi: 10.1016/j.omtn.2019.08.026. Epub 2019 Sep 9.
10
CircRNAs and cancer: Biomarkers and master regulators.
Semin Cancer Biol. 2019 Oct;58:90-99. doi: 10.1016/j.semcancer.2018.12.002. Epub 2018 Dec 11.
Zotero 插件